• Blood pressure and urinary protein currently useful for monitoring renal function • Potential for novel biomarkers such as Cystatin-C, NGAL and IL-6 in the future but further research required in this population • Minimize nephrotoxic drugs • Low Creatinine may not be a reliable method of monitoring for renal dysfunction in CP. Here, LCN2 is linked to Abnormal renal physiology.